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ABSTRACT Chitin is an essential component of the cell wall of Cryptococcus neofor-
mans conferring structural rigidity and integrity under diverse environmental condi-
tions. Chitin deacetylase genes encode the enyzmes (chitin deacetylases [Cdas]) that
deacetylate chitin, converting it to chitosan. The functional role of chitosan in the
fungal cell wall is not well deﬁned, but it is an important virulence determinant of C.
neoformans. Mutant strains deﬁcient in chitosan are completely avirulent in a mouse
pulmonary infection model. C. neoformans carries genes that encode three Cdas
(Cda1, Cda2, and Cda3) that appear to be functionally redundant in cells grown un-
der vegetative conditions. Here we report that C. neoformans Cda1 is the principal
Cda responsible for fungal pathogenesis. Point mutations were introduced in the ac-
tive site of Cda1 to generate strains in which the enzyme activity of Cda1 was abol-
ished without perturbing either its stability or localization. When used to infect
CBA/J mice, Cda1 mutant strains produced less chitosan and were attenuated for
virulence. We further demonstrate that C. neoformans Cda genes are transcribed dif-
ferently during a murine infection from what has been measured in vitro.
IMPORTANCE Cryptococcus neoformans is unique among fungal pathogens that
cause disease in a mammalian host, as it secretes a polysaccharide capsule that hin-
ders recognition by the host to facilitate its survival and proliferation. Even though it
causes serious infections in immunocompromised hosts, reports of infection in hosts
that are immunocompetent are on the rise. The cell wall of a fungal pathogen, its
synthesis, composition, and pathways of remodelling are attractive therapeutic tar-
gets for the development of fungicides. Chitosan, a polysaccharide in the cell wall of
C. neoformans is one such target, as it is critical for pathogenesis and absent in the
host. The results we present shed light on the importance of one of the chitin
deacetylases that synthesize chitosan during infection and further implicates chi-
tosan as being a critical factor for the pathogenesis of C. neoformans.
KEYWORDS chitin deacetylase, catalytic site, cell wall localization, chitosan, metal
binding site, fungal virulence
Cryptococcus is a major fungal pathogen of immunocompromised patients andaccounts for 15% of AIDS-related deaths annually (1). Due to the presence of a
outer polysachharide capsule and a cell wall that is both complex and dynamic, it has
been able to infect animal hosts and inhabit diverse environmental niches with a global
presence (2–5). Two species, Cryptococcus neoformans and Cryptococcus gattii, are
responsible for most clinical cases with C. neoformans affecting mainly immunocom-
promised individuals, while infections in immunocompetent people have been gener-
ally attributed to C. gattii (6, 7). There are exceptions, as C. gattii has been isolated from
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individuals infected with HIV, and certain genotypes of C. neoformans infect persons
presumed to be immunocompetent (8, 9).
Chitin, a polymer made up of repeating units of -1, 4 N-acetyl-D-glucosamine is an
important component of the fungal cell wall matrix and is critical for maintaining cell
wall integrity (10). Among the pathogenic fungi, C. neoformans is one of the few
pathogens reported to efﬁciently deacetylate chitin to convert it to chitosan in the cell
wall (11–13). The cell wall is essential for fungal survival. Since the majority of its
components are unique to fungi and absent from the host, they present an attractive
target for developing antifungal therapeutics. The cell wall is a dynamic organelle
whose content and composition undergo constant modiﬁcation in response to internal
cellular homeostasis and external environmental cues, thereby enabling the fungal cells
to survive under diverse stress conditions. However, this exclusive presence of cell wall
components in a fungal pathogen makes them vulnerable to being sensed as
pathogen-associated molecular patterns (PAMPs) by different pattern recognition re-
ceptors (PRRs) on host immune cells which in turn activate speciﬁc signaling pathways
that orchestrate anticryptococcal defense mechanisms (14). To evade these host de-
fense mechanisms, C. neoformans has evolved multiple resistance strategies such as
shielding PAMPs from host recognition receptors, decoration of the surface or secretion
of vesicles with molecules that skew host immune responses favoring fungal survival,
mechanisms that counter host-induced oxidative and nitrosative stresses, and the
ability to switch its morphology (15–21). While the encapsulation of the yeast with the
polysaccharide capsule helps them to prevent host receptor engagement, shed cap-
sular material also inhibits proinﬂammatory immune responses. By producing melanin,
C. neoformans laccase stabilizes the cell wall and protects yeast cells from killing by
microbicidal peptides, ingestion by macrophages, and killing by alveolar macrophages
(22–24).
The chitin ﬁber cross-links glucans, thereby securing the integrity of the cell wall
under different conditions of growth and during infection. However, the presence of
chitin in the cell wall makes the yeast vulnerable to detection by the host immune
system and degradation by host chitinases. Studies of mice and humans identiﬁed
chitinases or chitinase-like proteins (C/CLP) belonging to a family of 18 glycosyl
hydrolases that either degrade or bind to chitin polysaccharides. Some of these
proteins include acidic mammalian chitinase, chitotriosidase, oviductin, and the
chitinase-like proteins CHIL3, CHI3L1, CHI3L2, and CHIL4 (14). These data indicate that
mammalian hosts have evolved robust immunologic defense strategies to deal with
chitin-containing microbes. In addition to infecting mammals, Cryptococcus has also
been reported to colonize various plant species where it encounters chitinase-mediated
plant defense (25, 26). Furthermore, as Cryptococcus is a soil fungus, it is constantly
exposed to chitinases from soil bacteria and amoeba where it has to protect its cell wall
chitin from these microbial enzymes (27, 28). In Saccharomyces cerevisiae, chitosan is
reported to be present only in the ascospore wall and is responsible for the increased
resistance of the spores to environmental stress conditions (29–31). Microbial chitinases
have been shown to be less effective at degrading deacetylated chitin or chitosan (32).
In C. neoformans, chitin synthase Chs3 and chitin synthase regulator Csr2 comprise
the Chs/Csr system that produces the majority of vegetative cell wall chitin that is
converted to chitosan. Three chitin deacetylases (Cdas) are expressed (Cda1, Cda2, and
Cda3) with each contributing to chitosan synthesis. Strains of C. neoformans with either
CHS3, CSR2, or all three chitin deacetylase genes (CDA1, CDA2 and CDA3) deleted lack
chitosan and have a common set of phenotypes, including sensitivity to a variety of cell
wall stress conditions, and are rapidly cleared from infected mouse lungs (13). This
indicates that chitosan is essential for the proper maintenance of cell wall integrity and
virulence of C. neoformans, and Chs3, Csr2, and the Cdas are the principal proteins that
catalyze its biosynthesis (11, 12).
Deletion of individual Cda genes did not affect the amount of cell wall chitosan
when the yeast cells were grown in yeast extract-peptone-dextrose (YPD) medium, and
they did not exhibit sensitivity to any of the cell wall stress conditions (12). Since we
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discovered that chitosan is critical for establishing infection in mammalian hosts, we
wanted to investigate the role of individual Cda genes in chitosan biosynthesis during
infection. The results presented here indicate that, of the three C. neoformans chitin
deacetylases, Cda1 is the major contributor of fungal pathogenesis.
All three chitin deacetylases share similar protein sequence motifs for a cleavable
N-terminal signal sequence and for C-terminal addition of a glycosylphosphatidylinosi-
tol (GPI) anchor. C. neoformans Cda2 (initially named MP98) was shown to be a potent
stimulator of CD4 T cells (33). Recently, recombinant proteins of C. neoformans Cda1,
Cda2, and Cda3 expressed in Escherichia coli were shown to induce protective immunity
in mice against a C. neoformans infection when used as vaccines and delivered by
glucan particles (34). These data indicate that C. neoformans Cda proteins have an
inherent ability to modulate host immune responses. Therefore, we wanted to rule out
the possibility that the absence of Cda1 protein in cda1 cells is responsible for its
attenuated virulence. We also sought to distinguish whether the role of Cda1 in fungal
pathogenesis depends on the presence of the protein as a component of the cell wall,
its enzyme activity, or both of these features. To address this, we introduced loss-of-
function point mutations in the catalytic residues of Cda1. Our ﬁndings revealed that
Cda1 with its intact chitin deacetylase enzyme activity rather than its mere presence in
the cell wall is necessary for virulence, implicating its role in chitin deacetylation as a
critical factor for mediating fungal pathogenesis.
RESULTS
C. neoformans chitin deacetylases are functionally redundant under in vitro
growth/stress conditions. Previously we showed that deletion of three Cda genes was
required to generate a chitosan-deﬁcient strain of C. neoformans. This chitosan-
deﬁcient strain was found to be sensitive to growth when exposed to cell wall stressors
and was avirulent in a murine model of infection (12, 13). This raised questions about
the role each Cda had in chitosan biogenesis and virulence. We have already demon-
strated that deletion of single Cda genes in C. neoformans did not affect the amount of
cell wall chitosan when cultured in YPD at 30°C. Consistent with this, these strains did
not display sensitivity to growth when exposed to either various cell wall stressors or
to growth at 37°C. With a pulmonary infection, C. neoformans encounters multiple
stresses such as different pH environments (pH 7 for the alveolar sac or pH 4 for the
phagolysosome), limited nutrients, and exposure to reactive oxygen or nitrogen spe-
cies. To assess the ability of the single Cda deletion strains to grow under these
conditions, we measured their growth rate in a minimal medium of yeast nitrogen base
(YNB) at two different pH values, pH 4 and pH 7, at 37°C. We found no difference in the
rate of growth of each single deletion strain compared to their wild-type progenitor
(data not shown). Similarly, growth rates of single Cda deletion and wild-type strains in
RPMI 1640 medium containing 10% FBS at 37°C in the presence of 5% CO2 were similar
(data not shown). Next, we spotted serial dilutions of yeast cultures on YNB agar (pH 4)
in the presence of hydrogen peroxide (H2O2) (1 mM) or sodium nitrite (NaNO2)
(0.75 mM). None of the single deletion strains had their growth altered by adding these
compounds that generate reactive oxygen and nitrogen species, respectively. Overall,
we could not ﬁnd a phenotype for loss of a single Cda gene based on the ability of C.
neoformans to grow under conditions that simulate some of the stresses they poten-
tially encounter in a host.
Deletion of CDA1 severely attenuates C. neoformans virulence. Due to the
critical importance of chitosan during infection, we wanted to determine whether its
synthesis is dependent on any one of the three Cda genes during growth in the
infected lung. To test this, we measured the virulence of each Cda deletion strain by
intranasal infection of CBA/J mice. Deletion of CDA1 rendered C. neoformans consid-
erably less virulent than the wild-type KN99 strain (Fig. 1A). One of ten mice succumbed
to infection, and the other nine mice looked very healthy throughout the length of the
experiment without any sign of sickness (60 days postinfection [PI]). The deletion of
either CDA2 or CDA3 did not impact virulence. Mice infected with either a cda2 or
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cda3 strain displayed comparable median survival times (17 days PI) to that of animals
infected with wild-type KN99 (15 days PI). The importance of CDA1 for fungal virulence
is further supported by the observed restoration of virulence when the cda1 strain
had a copy of the CDA1 gene reintegrated at the endogenous CDA1 locus. Infection
with KN99, cda2, cda3, and cda1::CDA1 strains all showed signiﬁcant fungal bur-
dens ranging from 7.8 106 to 3.3 108 CFU/lung with a mean CFU/lung of 1.4 108,
1.1 108, 2.6 107, and 7.7 107, respectively, for animals infected with KN99, cda2,
cda3, and cda1::CDA1 strains at 15 to 17 days PI (n 10), when mice lost 20% of their
preinoculation body weight, which was determined to establish the endpoint of the
survival experiment. At these time points, fungal burdens in the brains ranged from
4 102 to 7 104 CFU/brain with a mean CFU/brain of 1 104, 4 103, 1.8 103, and
1.7 104, respectively, for animals infected with KN99, cda2, cda3, and cda1::CDA1
strains. In contrast, attenuated virulence of the cda1 strain was accompanied by a slow
and incomplete clearance of the mutant yeast from the infected host. Mice were
analyzed for fungal burden assays at 60 days PI, and there were variable numbers of
FIG 1 C. neoformans cda1 strain displays severely attenuated virulence. (A) CBA/J mice (4 to 6 weeks
old, female) were infected intranasally with 105 CFU of each strain. Survival of the animals was recorded
as mortality of mice for 60 days postinfection. Mice that lost 20% of their body weight were considered
ill and sacriﬁced. Data are representative of two independent experiments with 10 animals for each
strain. Virulence was determined using Mantel-Cox curve comparison with statistical signiﬁcance deter-
mined by the log rank test (P 0.0001 comparing KN99 with the cda1Δ strain). (B) Fungal burden in the
lungs of mice infected with indicated strains at different days after infection. Data are the average of two
experiments with four mice per group at each time point. The dashed line indicates the CFU of the initial
infection for each strain.
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CFU in lungs (ranging from 1 104 to 5.8 105 with a mean CFU/lung of 2.8 105)
and in the brain (ranging from 0 to 8.3 105 with a mean CFU/brain of 8.7 104).
Some animals had begun to clear the infections, since the CFU/lung was around 10-fold
less than the inoculum level.
We next wanted to determine whether there is a difference in the levels of fungal
burden of different mutant strains in the lung soon after infection. To do this, we
infected CBA/J mice with 105 colony-forming units (CFU) of the wild-type strain and the
individual Cda deletion strains. At days 2, 7, and 15 PI, lungs from the infected animals
were subjected to fungal burden assays. As shown in Fig. 1B, KN99, cda2, cda3, and
cda1::CDA1 strains all showed increased fungal burden days after infection. However,
the fungal burden in the lungs of animals infected with the cda1 strain stayed
constant and was similar to the initial inoculum. The attenuated virulence of the cda1
strain was apparent not only by reduced morbidity but also by the reduced fungal
burden in the lungs during the ﬁrst 2 weeks PI.
C. neoformans Cda1 plays a major role in the synthesis of chitosan during
infection. The ability to synthesize chitosan is important for the integrity of the C.
neoformans cell wall, since chitosan-deﬁcient strains displayed sensitivity to growth
under cell wall stress conditions (12). Individual Cda deletion strains did not exhibit
either a cell wall defect or sensitivity to cell wall stress conditions when grown in YPD
(12; data not shown). Therefore, we measured chitosan levels in wild-type, single Cda
deletion strains, and the corresponding CDA1 complemented strains using the
3-methyl-2-benzothiazolinone hydrazone hydrochloride hydrate (MBTH) method de-
scribed in Materials and Methods. Strains were grown in YPD for 2 days, similar to the
way inocula were grown for the virulence assay. We observed no signiﬁcant differences
in the cellular chitosan levels between the wild-type KN99 strain and the corresponding
single Cda deletion strains (Fig. 2A). However, since the cda1 strain was the only strain
that displayed attenuated virulence in the mouse survival experiment, we asked
whether deletion of CDA1 speciﬁcally affected the ability of the cells to synthesize
chitosan either in the infected lung or when grown under conditions that mimic the
host, such as RPMI 1640 medium containing 10% fetal bovine serum (FBS), 5% CO2, and
37°C. To test this hypothesis, we grew cells in YPD at 30°C for 48 h and then transferred
the cells to RPMI medium containing 10% FBS at 37°C in the presence of 5% CO2 and
grew the cells for 5 more days. After 5 days under host-mimicking conditions, the levels
of chitosan in the cda1 cells were signiﬁcantly reduced (2.5-fold less than that of
KN99), whereas the CDA1 reconstituted strain showed wild-type levels of chitosan
(Fig. 2B). This difference in the amount of chitosan was not observed for either the
cda2Δ and cda3 cells (Fig. 2B). Next, we tested whether chitosan production in the
cda1 cells was affected when the cells were grown in infected lung. To do this, we
inoculated mice with 107 CFU of strain KN99 or the cda1 strain. At 7 days PI, we
harvested the fungal cells from the infected lung and measured the cellular chitosan
content. Again, as shown in Fig. 2C, unlike YPD growth conditions, but similar to the
RPMI growth conditions, the levels of chitosan present in the cda1 strain were
signiﬁcantly reduced (2.4-fold less) compared to KN99 cells, whereas the strain recon-
stituted with CDA1 showed wild-type levels (Fig. 2C). On the basis of these data, we
concluded that Cda1 removes the majority of the acetyl groups from chitin in the
generation of chitosan during host infection and that the inability to produce chitosan
is likely responsible for the attenuated virulence of the cda1 strain.
Speciﬁc mutation of conserved residues at the catalytic site abolishes chitin
deacetylase activity of C. neoformans Cda1. C. neoformans Cda genes were initially
identiﬁed by the presence of a chitin/polysaccharide deacetylase domain in their
putative protein products. Out of the four predicted deacetylase genes, two of them
(Cda2/MP98 and Fpd1/d25) were previously shown to be highly immune reactive
mannoprotein antigens (33, 35). Our previous genetic study involving the generation of
a chitosan-deﬁcient cda1cda2cda3 strain indicated that Fpd1 has an insigniﬁcant
role in the deacetylation of cell wall chitin (12). All four proteins are predicted to contain
a N-terminal signal sequence, and the three Cda proteins each have a C-terminal site
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November/December 2018 Volume 9 Issue 6 e02087-18 mbio.asm.org 5
 o
n








FIG 2 C. neoformans Cda1 plays a major role in the synthesis of chitosan under host infection
conditions. (A) Chitosan levels of strains grown in YPD. The indicated strains were grown in YPD for
48 h. The amount of chitosan in the cell wall of the strains was quantiﬁed by the MBTH assay. Data
are the averages for three biological experiments with two technical replicates and are expressed as
nanomoles of glucosamine per milligram (dry weight) of yeast cells. (B) Chitosan levels of strains
grown in RPMI containing 10% FBS and 5% CO2 at 37°C for 5 days. The indicated strains were grown
in YPD for 48 h. Yeast cells were harvested, washed with PBS, and inoculated at 500 cells/l in RPMI
containing 10% FBS and incubated for 5 days at 37°C in the presence of 5% CO2. At the end of
incubation, chitosan was measured by the MBTH assay and expressed as nanomoles of glucosamine
per milligram (dry weight) of cells. Data represent the averages for three biological experiments with
two technical replicates. (C) Chitosan levels of strains growing in the murine lung. Mice (CBA/J; four
mice per group) were intranasally inoculated with 107 CFU of each strain. On day 7 PI, lungs were
excised and homogenized, and the lung tissue was removed by alkaline extraction, leaving the
fungal cells to be harvested, counted, and subjected to the MBTH assay. Data were expressed as
nanomoles of glucosamine per 107 cells. Signiﬁcant differences between the groups were compared
by one-way ANOVA, followed by Bonferroni’s multiple-comparison test (P  0.0001 comparing KN99
with any other strain; ns, not signiﬁcant).
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for the addition of a glycosylphosphatidylinositol (GPI) anchor, which is not present for
Fpd1 (12). Accordingly, Cda2 was demonstrated to be distributed in the cell wall, cell
membrane, and secreted fractions. The presence of Cda2 in the cell membrane was
found to be critical for its effective deacetylase activity (36). Therefore, we wanted to
characterize the deacetylase enzyme activity of Cda1 and its distribution in the cell and
also wanted to determine to what extent Cda1 as an immunogen or Cda1 as the
enzyme contributes to the virulence of C. neoformans. To this end, we generated a
strain of C. neoformans in which catalytic residues of Cda1 were mutated to abolish its
chitin deacetylase activity, while otherwise causing no alteration to its stability and
cellular localization.
The mechanisms of deacetylase catalysis were ﬁrst reported for the pathogen
Streptococcus pneumoniae and the enzyme peptidoglycan GlcNAc deacetylase (Sp-
PgdA). In this study, Blair and coworkers found that the Asp-275 residue coordinates
acetate binding and the conservative substitution of it with asparagine completely
inactivated the enzyme without adversely affecting protein stability (37). Additionally,
they discovered a zinc binding triad in SpPgdA consisting of amino acids Asp-276,
His-326, and His-330 and that mutation of His-326 to Ala also abolished enzyme activity
(37). The same authors extended their investigation to determine the crystal structure
and the mechanism of catalysis of a Cda from Colletotrichum clindemuthianum, a plant
fungal pathogen (38). They demonstrated that Asp-49, Arg-142, and His-206 of C.
clindemuthianum are directly involved in acetate binding and are critical for enzyme
catalysis. They also identiﬁed Asp-167, His-216, and His-220 as the zinc binding triad
important for deacetylase activity (38). We aligned our three chitin deacetylase protein
sequences with the peptidoglycan deacetylases from S. pneumoniae and C. clindemuthi-
anum and identiﬁed the three catalytic residues, D166, R254, and D294 in Cda1, as well
as zinc-binding residues, D167, H216, and H220 in Cda1 (Fig. 3). We disrupted the
acetate binding residues in Cda1: cda1D166N,R254A,D294N (Cda1CS:Cda1 catalytic site mu-
tant) and the zinc binding pocket, cda1D167N,H216A,H220A (Cda1MB:Cda1 metal binding
pocket mutant). The designs of the DNA constructs used for gene replacement at the
CDA1 locus are shown in Fig. S1 in the supplemental material. The cda1Δ and cda23
strains (12) were biolistically transformed with the constructs shown in Fig. S1. We
FIG 3 Identiﬁcation of potential active site residues of C. neoformans Cda1 by sequence alignment.
Multiple-sequence alignment of polysaccharide deacetylases. The sequences of C. neoformans Cdas (Cn
Cda1, Cn Cda2, and Cn Cda3 [CNAG_05799, CNAG_01230, and CNAG_01239, respectively]) were aligned
by the T-coffee program to the peptidoglycan N-deacetylase of S. pneumoniae (Sp PgdA) (GenBank
accession number EDK82277.1) and Cda of C. lindemuthianum (Cc Cda) (GenBank accession number
AAT68493.1) (60, 61). Identical amino acids are in black boxes, and similar amino acids are in gray boxes.
The conserved residues corresponding to catalytic site and metal binding pocket are colored red and
blue, respectively.
Cell Wall Chitosan Is Critical for Fungal Pathogenesis ®
November/December 2018 Volume 9 Issue 6 e02087-18 mbio.asm.org 7
 o
n








conﬁrmed each transformant by diagnostic PCR and Southern blotting (data not
shown). The cda1 strain was created by replacing CDA1 with the hygromycin (HYG)
drug cassette. Thus, we identiﬁed successful transformants of the cda1 strain by the
loss of the hygromycin (HYG)-resistant drug cassette when it was replaced with the
mutated CDA1 constructs (Fig. S1). In the case of the transformation of the cda23
strain with the cda1CM, cda1MB, and CDA1 alleles, we initially screened for G418
resistance and then serially passaged positive transformants on nonselective media
before screening them again on G418 drug plates. We then identiﬁed the transformants
by diagnostic PCR at the 5= junction of the integration event. The PCR-positive isolates
showed a slow growth phenotype in YPD with small colonies similar to those of the
cda123 strain, indicating that the mutant allele has replaced its wild-type gene at
the desired CDA1 locus and that the mutation of the predicted catalytic site may have
abolished the chitin deacetylase activity (12).
We ﬁrst wanted to verify that the speciﬁc point mutations engineered in the CDA1
gene did not affect Cda1 protein expression and turnover. We measured the mutated
Cda1 protein levels present in the KN99 or cda23 background by Western blot
analysis using a C. neoformans Cda1-speciﬁc polyclonal antibody. We observed stable
production of the mutated Cda1 protein as seen in the lysates of two independent
isolates of the catalytic point mutants (Cda1CS: isolates A and B) generated in the KN99
background (using the cda1 strain as the recipient strain) (Fig. 4A, Cda1CS, isolates A
and B). The absence of a Cda1-speciﬁc signal from the lysates of cda1 cells established
the speciﬁcity of the polyclonal antibody (Fig. 4A). We were also able to engineer
mutations at residues Asp-167, His-216, and His-220 to Asn, Ala, and Ala residues,
respectively, to disrupt the predicted metal binding pocket. Two independent isolates
(Cda1MB; isolates A and B) were used for immunoblot analysis. However, we did not see
Cda1-speciﬁc signal, suggesting that disruption of the zinc binding pocket destabilized
FIG 4 Effects of changes in amino acids to the catalytic site and metal binding site of Cda1 on protein
stability. (A) Western blot analysis of the whole-cell lysates of the wild-type strain and the corresponding
Cda1 mutant strains. Equal amounts of protein quantiﬁed by BCA protein assay were separated on a 12%
Stain-Free Tris-glycine gels. Proteins were transferred to a nitrocellulose membrane and probed with a
C. neoformans Cda1-speciﬁc polyclonal antibody. (B) Total proteins detected by the photo-activation of
the stain-free gel used in the immunoblot shown in panel A. (C) Immunoblot analysis of the whole-cell
lysates of catalytic and metal binding site mutants generated in cda23 background. (D) Visualization
of total proteins present in each lane of the blot in panel C using stain-free technology.
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the protein and targeted it for degradation (Fig. 4A). Equal amount of the total protein
loaded onto each lane as determined by the bicinchoninic acid (BCA) assay was veriﬁed
by photo-activating the stain-free gel using stain free imaging technology (Fig. 4B)
(Bio-Rad Laboratories, USA) (39). Similar results were obtained when the lysates of
mutants generated in the cda23 background were subjected to Western blot
analysis, as shown in Fig. 4C, and the total protein present in each lane was visualized
by the activation of the stain-free gel (Fig. 4D).
We have previously shown that Cda2 is localized in the plasma membrane, cell wall,
and secreted fractions of C. neoformans and that localization of Cda2 in the cell
membrane is essential for the synthesis of chitosan, whereas cell wall-localized Cda2 is
not efﬁcient at producing the polymer (36). We thus wanted to determine whether
replacement of the catalytic residues in Cda1 affected its localization. We fractionated
independently isolated strains of mutated Cda1 present in the KN99 background and
subjected them to Western blot analysis with the Cda1-speciﬁc antibody. Mutation of
the catalytic residues of the Cda1 protein (Cda1CS) had no measurable effect on its
localization in the membrane fraction compared to its wild-type Cda1 counterpart as
can be seen on lanes marked M for membrane and CW for cell wall fractions in Fig. 5.
Thus, disruption of the catalytic residues of Cda1 did not impact its stability or its
localization.
Previously we have shown that chitosan-deﬁcient C. neoformans strains generated
either by the deletion of CHS3, CSR2, or all three Cda genes (CDA1, CDA2, and CDA3)
exhibited cell wall defects when plated on media that induced cell wall stress and did
not stain with eosin Y, an anionic dye that binds preferentially to chitosan (11).
Therefore, we reasoned that if the speciﬁc mutations created in the catalytic site of
Cda1 interfere with its enzyme activity, then the mutant strain generated in the
cda23 background (cda23cda1CS) should also exhibit phenotypes similar to those
shown by chitosan-deﬁcient strains. The chitosan-deﬁcient strains show a budding
defect in which daughter cells fail to separate from the mother cell, generating clumps
of cells when grown in rich media (11, 12) (cda123 strain in Fig. 6A). We observed
a similar budding defect for two independent isolates (A1 and B4) of the mutated Cda1
in the cda23cda1CS strain (Fig. 6A). This phenotype is consistent with each isolate
bearing an enzymatically inactive Cda1. The control strain with wild-type CDA1 in a
cda23 background exhibits no budding defect (isolate B5; Fig. 6A). Previously we
demonstrated that the lack of Eosin Y staining of cda123 cells correlated with the
absence of chitosan (12). The two independent isolates of the mutant strain
(cda23cda1CS A1 and B4 isolates) also showed no binding of Eosin Y to the cell wall,
similar to the cda123 strain (Fig. 6B). The binding of Eosin Y is restored in the
cda23 strain in which wild-type Cda1 is being expressed (cda23CDA1:B5 strain in
Fig. 6B). We further conﬁrmed the chitosan deﬁciency of these mutant strains by the
chemical determination of cell wall-associated chitosan using the MBTH assay (Fig. 6C).
Earlier studies have shown that the absence of chitosan in the cell wall rendered cells
FIG 5 Disruption of C. neoformans Cda1 catalytic site did not interfere with its cellular localization. The
indicated strains were streaked onto YPD agar and incubated for 4 days at 30°C. Cells were collected from
the plates, washed with PBS, and subjected to subcellular fractionation. Equal quantities of protein as
determined by the BCA method were separated on 10% SDS gel and analyzed by Western blotting using
a C. neoformans Cda1-speciﬁc polyclonal antibody. Lanes: L, total cell lysate; C, cytosol fraction; M, cell
membrane fraction; CW, cell wall fraction.
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FIG 6 Point mutations in the catalytic site of Cda1 expressed in a cda23 strain results in chitosan deﬁciency and phenotypes similar
to those of the chitosan-deﬁcient cda123 strain. (A) Cda1 catalytic point mutant strains generated in the cda23 background display
a budding defect when grown in YPD medium similar to the budding defect observed for a chitosan-deﬁcient cda123 strain. The
wild-type and mutant strains were grown in YPD for 36 h, collected, washed, and visualized with an Olympus BX61 microscope, and
photographs were taken at 100 magniﬁcation. (B) The wild-type, corresponding Cda deletion, and mutant strains were grown as
described above in panel A and stained with Eosin Y to detect cell wall chitosan. Bright-ﬁeld and ﬂuorescence isothiocyanate panels are
(Continued on next page)
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sensitive to cell wall stress reagents (12). We tested two independent isolates of
cda23cda1CS with the cell wall stressors 1 M NaCl and 0.01% or 0.03% SDS and
observed phenotypes similar to those of the cda123 strain (Fig. 6D). We did not
observe the cell wall stress phenotypes in the control cda23CDA1 strains. Thus, we
conclude that site-speciﬁc mutation of the conserved catalytic residues of Cda1 abol-
ishes its chitin deacetylase activity while retaining its protein stability and cellular
location, even in the absence of the CDA2 and CDA3 genes.
Activity of Cda1 is primarily responsible for fungal pathogenesis. The cda1
single deletion strain exhibits decreased levels of cell wall chitosan in vitro when
cultured under host-mimicking conditions (Fig. 2B). Therefore, we wanted to determine
whether expression of the cda1CS allele in a background with Cda2 and Cda3 had a
similar effect on the cell wall chitosan under host-mimicking conditions. We measured
chitosan levels of two independent isolates of cda1CS (isolates A and B) after growing
the cells in either YPD or RPMI containing 10% FBS at 5% CO2 and 37°C. The KN99,
cda1, and cda1::CDA1 strains served as control strains. We observed no signiﬁcant
differences in the amount of cell wall chitosan between strains when grown in YPD
medium (Fig. 7A). However, we found signiﬁcant decreases in chitosan for both isolates
(isolates A and B) of the cda1CS strain and for the cda1 strain compared to controls
when grown in RPMI containing 10% FBS at 5% CO2 and 37°C (Fig. 7B). These data
validate the hypothesis that in C. neoformans, Cda1 has a major role in the biosynthesis
of chitosan under conditions that partially simulate host conditions, and the mutation
of the conserved catalytic site residues eliminates its chitin deacetylase enzyme activity.
We next tested the virulence of the catalytic point mutant strains in a mouse
inhalation model. The point mutations of the catalytic site of Cda1 protein rendered the
mutant strain severely attenuated for virulence, similar to the cda1 strain (Fig. 8). We
measured the fungal burden in the lungs of the surviving mice at the endpoint of the
FIG 6 Legend (Continued)
shown. Photographs were taken at 100 magniﬁcation. (C) Quantitative determination of cell wall chitosan in wild-type and various Cda
deletion and mutant strains by the MBTH assay. Cells were grown in YPD for 48 h, collected, washed, and used for the assay. Data
represent the averages for three biological and two technical replicates. Signiﬁcant differences between the groups were compared by
one-way ANOVA, followed by Dunnett’s multiple-comparison test (****, P 0.0001 comparing the chitosan amount for each strain to that
for the cda23 strain). (D) Wild-type and various C. neoformans Cda deletion and catalytic point mutant strains were grown in YPD for
36 h. Cells were harvested, washed, and diluted to an OD650 of 1.0. Four microliters of 10-fold serially diluted cell suspension was spotted
on YPD agar alone and YPD agar containing cell wall stress reagents NaCl and SDS. The plates were incubated for 4 days at 30°C and
photographed.
FIG 7 C. neoformans Cda1 catalytic point mutant strains fail to produce chitosan when grown under host-
mimicking conditions. (A) Yeast strains were grown in YPD at 30°C for 72 h. Cells were collected, washed, and used
for the measurement of cell wall chitosan by the MBTH assay. (B) The indicated strains were initially grown in YPD
for 36 h, then collected, washed, and inoculated at a cell density of 500 cells/l in RPMI medium containing 10%
FBS, and incubated for 5 days at 37°C and 5% CO2. At the end of incubation, cells were collected, washed, and used
for chitosan measurement by the MBTH assay. Data are the averages for three biological experiments with each
experiment having two technical replicates. Signiﬁcant differences between the groups were compared by
one-way ANOVA, followed by Bonferroni’s multiple-comparison test (****, P 0.0001 comparing chitosan levels of
strain KN99 to each other strain).
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survival experiment (60 days PI) and found similar fungal burdens in the lungs of the
mice infected with cda1CS strains compared to those infected with a cda1 strain (data
not shown). These results strongly suggest that the mere presence of Cda1 protein is
not enough to cause fungal pathogenesis but that its chitin deacetylase enzyme
activity is essential for virulence in this model.
C. neoformans CDA1 is speciﬁcally upregulated in cells growing in the mouse
lung. In order to begin to understand the mechanism of Cda1-mediated chitosan
production during infection, we measured the transcriptional response of Cdas during
a pulmonary infection. We inoculated mice with 107 CFU of strain KN99 and harvested
the fungal cells from the lung on day 7 PI. We monitored the Cda expression levels
using quantitative PCR and compared RNA levels of the individual Cda genes to their
levels in the inoculum, which was grown in YPD for 2 days. The CDA1 transcript was
highly upregulated (9-fold), CDA2 was modestly increased (2.5-fold), and CDA3
showed no change relative to their levels in the YPD inoculum (Fig. 9). These results
support the hypothesis that growth in the lung environment of the infected animal
FIG 8 Chitin deacetylase activity of C. neoformans Cda1 is critical for fungal pathogenesis. Mice (female
CBA/J; 4 to 6 weeks old) were inoculated with 105 CFU of the indicated yeast strains by intranasal
instillation. Mice were monitored for up to 60 days PI for survival by monitoring their body weight.
Animals that lost 20% of their weight during inoculation were considered moribund and were eutha-
nized. Data for each strain (n  10 mice) are the combined results of two experiments, each with ﬁve
animals. Survival curves were compared by log rank (Mantel-Cox) test (P 0.0001 comparing strain KN99
to cda1 or cda1CS isolate A or cda1CS isolate B).
FIG 9 C. neoformans CDA1 is transcriptionally upregulated during host infection. Mice were inoculated
with 107 CFU of KN99 cells. At day 7 PI, the lungs were excised and homogenized, and fungal cells were
harvested and used for the isolation of total RNA. Total RNA (0.5 g) was used for the synthesis of cDNA,
which was subsequently subjected to quantitative real-time PCR using CDA1-speciﬁc primers. C. neofor-
mans 18S rRNA transcript levels were used as a reference gene. Transcript levels of the respective genes
in the cells used as inoculum served as control. Data are the averages for two independent experiments
each with three animals per group. Fold expression was calculated for each gene comparing the extent
of its upregulation in the lung samples to YPD-grown samples. Signiﬁcant differences in the expression
levels between genes were compared by ordinary one-way ANOVA, followed by Dunnett’s multiple-
comparison test. (****, P 0.0001 comparing fold expression of CDA1, CDA2, and CDA3 in the lung
samples to their respective levels in the inoculum sample grown in YPD).
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stimulates speciﬁc upregulation of CDA1, which in turn correlates with Cda1 being the
major contributor to chitosan biosynthesis.
DISCUSSION
C. neoformans grows vegetatively as a budding yeast and has a deﬁned sexual cycle
that culminates in the production of basidiospores. An infection with C. neoformans can
be initiated with either vegetative yeast or basidiospores (40). The yeast cell wall of C.
neoformans contains considerable amounts of chitosan (11, 13). While chitosan is found
in the walls of the ascospores in the nonpathogenic yeast S. cerevisiae, it is unknown
whether chitosan is present in the basidiospore wall of C. neoformans (29–31). However,
inhaled spores germinate and differentiate into the yeast form, and it is in this form that
either infection will proceed or the yeast will be cleared from the host. Cell wall
chitosan is dispensable when cryptococcal cells are cultured in standard growth
medium, but chitosan is necessary for growth during infection (11–13, 41). Therefore,
our goal was to identify and characterize the role of chitin deacetylases during a
pulmonary infection. We have shown that despite having three functional chitin
deacetylases, C. neoformans increases Cda1 transcription and employs Cda1 speciﬁcally
to augment the synthesis of cell wall chitosan in a mammalian host through its chitin
deacetylase enzyme activity; the chitosan produced by Cda1 is important for Crypto-
coccus to proliferate in the host lung.
The inability of the catalytic site mutants generated in the cda23 background to
produce chitosan while still expressing the mutant Cda1 protein clearly indicated that
we speciﬁcally targeted the chitin deacetylase activity of Cda1. Moreover, two inde-
pendent isolates of cda23cda1CS exhibited in vitro phenotypes, which were identical
to those of the cda123 strain, thus conﬁrming the complete lack of Cda1 enzyme
activity in cda1CS mutant strains. The cda1CS strain also exhibited phenotypes similar to
those of the cda1 strain both in their failure to produce chitosan when grown in
RPMI/10% FBS and 5% CO2 conditions and their inability to cause severe infection in
the lungs of CBA/J mice. This is the ﬁrst report in which the biosynthesis of chitosan and
maintaining its normal levels in the cell wall can be directly implicated with fungal
virulence.
Chitin deacetylases from several fungi have been reported to be active at diverse
locations (42–45). Very little is known about the activity of chitin deacetylases in C.
neoformans. In a previous report using a C. neoformans Cda2-speciﬁc monoclonal
antibody and a cell fractionation procedure, it was revealed that Cda2 is present in the
cytosol, membrane, cell wall, and secreted fractions (36). Although Cda2 was found in
all of the fractions, chitosan synthesis by Cda2 requires its membrane localization (36).
Therefore, in this study of Cda1, we wanted to make sure that mutation of its catalytic
site did not affect either the stability or localization of the mutant protein. Fortunately,
we found that the catalytic mutant form of Cda1 (cda1CS) was stably expressed and
enriched in the membrane fraction like its native Cda1counterpart. We did observe that
the total cell lysates prepared from mutant strains generated in the cda23 back-
ground showed decreased intensity in the activated stain-free gels for total protein
(Fig. 4D). This might be due to the presence of a signiﬁcant amount of capsular material
present in these lysates interfering with the protein separation and staining. We have
observed similar patterns for other chitosan-deﬁcient strains such as cda123,
chs3, and csr2 strains (unpublished results). In addition, the reported bigger capsules
produced by the chitosan-deﬁcient strains under vegetative growth conditions may
have contributed to the poor resolution/staining of the proteins produced from mutant
strains generated in the cda23 background (Fig. 4D) (12). Different metal ions have
been reported to activate chitin deacetylase enzyme activity. The type of the metal ion
required for enzyme activation is dependent on the enzyme source. We found that
mutation of the putative metal binding site interfered with the protein stability of Cda1
in both the wild-type and cda23 background. This is consistent with the reports that
metal ions of metalloproteins are important for the proper folding and stability of the
ﬁnal folded proteins (46). The chitin deacetylase genes are each expressed during
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vegetative growth, and each has a redundant role in the production of chitosan (12).
However, it is striking to see that Cda1 plays a major role during growth in the infected
lung.
It is interesting to note that at the end of the survival experiment, we did observe
fungal burden in the lung even though the animals looked very healthy, were active,
and gaining normal weight. The deletion of Cda1 did not affect the dissemination of
the yeast cells in the infected animal, since we did observe fungal burden in the brains
of some of the animals at the endpoint of survival experiments. This suggests that the
host immune system was able to arrest the rapid proliferation of the mutant cells but
failed to completely clear them. That there was substantial fungal burden in the brains
of some of the animals infected with the cda1 strain at the endpoint of the survival
experiment suggests that cda1 cells were able to exit the lung and either proliferate
in the blood or cross the blood brain barrier (BBB) and proliferate in the brain. We did
not see any correlation between the lung fungal burden and the corresponding
appearance of yeast cells in the brain, suggesting that the presence of fungal cells in
the brain did not require high CFU in the lung. In one of the animals, even though the
lung CFU was decreased by ﬁvefold compared to the inoculum level, it still harbored
signiﬁcant CFU in the brain.
Previous studies demonstrated that recombinant Cda1 when used with glucan
particles induced an effective protective immunity to Cryptococcus challenge infection
(34). We reasoned that the presence of Cda1 protein in the cda1CS mutants might
negatively inﬂuence the intensity of virulence compared to the virulence of the cda1
strain. However, we did not see any difference in either the virulence or lung fungal
burden at the endpoint of the survival experiment for cda1 and cda1CS infection. The
amount of Cda1CS protein present in cda1CS strain may not be sufﬁcient enough to
induce anticryptococcal host responses.
We have seen previously that chitosan-deﬁcient cells are rapidly cleared from the
host under certain conditions (13, 41). The loss of Cda1 does not render the cells
completely devoid of chitosan either when they are growing in the infected lung or
when they were incubated in culture under conditions that mimic the host. This
suggests that the presence of chitosan in the cell wall protects yeast cells from host
clearance. The level of chitosan in the cell wall is dynamic even when the cells are
growing in YPD conditions either for wild-type cells or for cda1Δ cells. Therefore, it is
possible that due to the absence of Cda1, cda1Δ cells may have either less chitosan or
have a chitosan with a diminished degree of deacetylation that may render them
sensitive to host chitinases. This uneven clearance of fungal cells in the lung may have
contributed to the observed persistence of fungal burden.
We have shown that loss of chitosan transforms C. neoformans cells into a strong
stimulator of host immune responses. The lungs of mice infected with 107 CFU of the
cda123 strain displayed a robust inﬂammatory response followed by complete
clearance of fungal cells (41). This suggests that the ability of the fungal cells to convert
chitin to chitosan is critical for masking the cell wall chitin from being recognized by
host chitinases. This is not unique to C. neoformans, since other plant-pathogenic fungi
have been shown to employ chitin-to-chitosan conversion as one of the mechanisms
to prevent host immune activation during infection. Recently, it has been shown that
Cda activity induces appressorium differentiation in the rice blast fungus Magnaporthe
oryzae. It is surprising that despite M. oryzae encoding seven putative chitin deacety-
lases, only one Cda (Cbp1) was critical for converting chitin to chitosan during appres-
sorium differentiation (47). In the tomato leaf mold Cladosporium fulvum, novel chitin
binding proteins have been discovered to bind chitin during plant infection to mask
chitin, thereby limiting triggering of plant immune responses (48, 49). These examples
are plant pathogens, but given the presence of chitinases in mammalian hosts, this
strategy could be effective for animal pathogens as well.
In C. neoformans, Cda2 and Cda3 appear to compensate for the loss of Cda1 when
strains are cultured in YPD medium but fail to do so during infection of CBA/J mice. Our
results suggest that production of chitosan during a pulmonary infection is largely
Upadhya et al. ®
November/December 2018 Volume 9 Issue 6 e02087-18 mbio.asm.org 14
 o
n








dependent on the level of Cda1 transcription. Transcriptional regulation of Cda expres-
sion and Cda activity was initially found for S. cerevisiae, where the transcription of its
CDA1 and CDA2 genes is restricted to sporulation (29, 50). C. neoformans transcription
factor RIM101, a highly conserved pH response regulator, has been shown to negatively
affect cell wall remodeling in the yeast growing either in the infected lung or under
tissue culture conditions (Dulbecco’s modiﬁed Eagle’s medium [DMEM] with 5% CO2 at
37°C). RIM101 was found to regulate the expression of eight of the twelve genes that
are predicted to play a role in the synthesis of chitin and chitosan. Under tissue culture
conditions, Rim101 was found to bind the CDA1 promoter suggesting that Cda1
expression is regulated by Rim101. However, unlike cda1, deletion of RIM101 did not
attenuate C. neoformans virulence, suggesting that factors other than RIM101 may play
an important role in the regulation of Cda1-mediated chitosan production (51–53).
Further characterization of the CDA1 promoter may provide insights into the roles of
transcription factors and signaling pathways that regulate chitosan biosynthesis. In
conclusion, understanding the mechanisms of chitosan biosynthesis and its regulation
during infection is important and is a novel avenue for developing therapeutic mole-
cules against cryptococcal infections.
MATERIALS AND METHODS
Fungal strains and media. KN99, a strain of C. neoformans serotype A (54), was used as the
wild-type strain and as progenitor of mutant strains. Strains are listed in Table 1. Strains were grown on
YPD (1% yeast extract, 2% bacto-peptone, and 2% dextrose). Solid media contained 2% bacto-agar.
Selective YPD medium contained 100 g/ml nourseothricin (NAT) (Werner BioAgents, Germany) and/or
200 g/ml G418 (Geneticin; Gibco Life Technologies, USA). RPMI 1640 (catalog no. 10-040 CM; Corning)
contained 10% fetal bovine serum (FBS) (catalog no. 26140; Gibco-Thermo Fisher Technologies).
Generation of predicted catalytic and metal binding mutant strains of Cda1. A diagram that
depicts the steps for making gene replacement constructs is shown in Fig. S1 in the supplemental
material. Scheme A describes the steps taken to construct wild-type and mutant CDA1 genes. Brieﬂy, two
separate 490-bp genomic DNA fragments (Cda fragment B) of C. neoformans CDA1 (CNAG_05799) in
which predicted catalytic and metal binding sites are located (encoding amino acids 154 to 302) were
chemically synthesized by Integrated DNA Technologies, USA. Nucleic acid substitutions to generate
mutations were introduced during gene synthesis. DNA regions that ﬂanked Cda fragment B were
ampliﬁed by PCR using gene-speciﬁc primers and KN99 genomic DNA as the template. The 5= ﬂanking
PCR product, Cda gene fragment A, was 1,479 bp and included 750 bp of the Cda1 promoter and DNA
encoding amino acids 1 to 153. The 3= ﬂanking PCR product, Cda gene fragment C, was 916 bp and
included DNA encoding amino acids 303 to 470 and 306 bp of the 3= untranslated region (UTR). All three
CDA1 gene fragments were assembled together using overlap PCR to generate wild-type or mutant
versions of the full-length CDA1 gene. The ﬁnal PCR products of 2,885 bp were cloned as described below
and sequenced to verify that no errors had been introduced during fusion and ampliﬁcation.
Construction of a plasmid to clone wild-type and mutant CDA1 gene fragments. Next, the CDA1
DNA generated by PCR fusion described above was cloned into a vector that enabled gene replacement
and selection of transformants on medium containing G418. First, a 809-bp genomic region encompass-
ing a region 2,032 bp upstream of the Cda1 translation start site (ATG) was ampliﬁed from genomic DNA
of strain KN99 to provide a 5= homologous region for targeted integration. This 809-bp fragment was
then fused to 2.9 kb of DNA encoding G418 resistance that had been ampliﬁed from the plasmid pMH12T
employing In-Fusion HD cloning (TaKaRa Bio, USA) to generate the CDA15’homologyG418 fragment
(55). Unique restriction sites were engineered in the primers for each fragment as shown in scheme B of









cda1 HYG KN99 12
cda2 NAT KN99 12
cda3 G418 KN99 12
cda23 NAT/Phleo 12
cda1::CDA1 G418 cda1 This study (RUCN1219)
cda1D166N,R254A,D294N (cda1CS) G418 cda1 This study (RUCN1218)
cda1D167N,H216A,H220A (cda1MB) G418 cda1 This study (RUCN1220)
cda23cda1D166N,R254A,D294N NAT/Phleo/G418 cda23 This study (JLCN 933)
cda23cda1D167N,H216A,H220A NAT/Phleo/G418 cda23 This study (JLCN 936)
cda23::CDA1 NAT/Phleo/G418 cda23 This study (JLCN 939)
cda1cda23 HYG/NAT/Phleo KN99 12
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Fig. S1. The CDA15’homologyG418 fragment was cloned into pMH12T at the NotI site after digesting
pMH12T with HindIII and NotI. The NotI site was preserved, while cloning eliminated the HindIII
restriction site to generate plasmid pCDA15primeG418. Different versions of the Cda1 gene fragment
(either wild type or mutant) were cloned at the unique PacI and NotI sites in the plasmid
pCDA15primeG418 to generate plasmids pCDA1A, pCDA1B, and pCDA1C containing wild-type, cata-
lytic site mutant, and metal binding site mutant forms of Cda1, respectively. Finally, XhoI digestion of
each of the plasmids was carried out to release the CDA1 gene fragment (containing sequences of the
wild-type and the corresponding point mutant versions) as shown in scheme B for biolistic transforma-
tion. The strain created after transformation of a construct containing a wild-type gene copy was
designated a cda1::CDA1 strain.
Transformation and characterization of C. neoformans mutants. Recipient strains of C. neofor-
mans were transformed biolistically following the protocol described earlier (55, 56). Drug-resistant
transformants that formed colonies in 3 to 5 days were passaged four times in liquid YPD medium before
reselection of drug resistance on agar. Transformants were further characterized by diagnostic PCR of
their genomic DNA using primers at the 5= and 3= junction of the integration site of the transforming
DNA. Southern blot hybridizations were done to verify the absence of random DNA integrations as
described previously (57).
Evaluation of C. neoformans to stress under in vitro conditions. Solid YPD medium was made
with the desired amount of either SDS or NaCl. To subject cells to oxidative and nitrosative stress, YNB
medium buffered to pH 4 with 1 M succinic acid was used with a ﬁnal concentration of 1 mM H2O2 or
0.75 mM NaNO2, respectively. For plating, wild-type and mutant strains were grown in liquid YPD for 24 h
at 30°C. Cells were diluted to an OD650 of 1.0, and 10-fold serial dilutions were made. Four microliters of
each dilution were spotted on the plate, and the plates were incubated for 2 or 3 days at the appropriate
temperature and photographed. Eosin Y staining was carried out as described earlier (12).
Cellular chitosan measurement.We optimized an MBTH (3-methyl-2-benzothiazolinone hydrazone)
(catalog no. 65875; Sigma-Aldrich, USA)-based chemical method for the measurement of cell wall
chitosan by the modiﬁcation of a previously reported assay for the quantiﬁcation of glycosaminoglycan
hexosamine (58). C. neoformans cells were collected by centrifugation and washed with distilled water,
and the cell pellets were lyophilized to measure their dry weight. The lyophilized material was suspended
in 10 ml of 6% (wt/vol) KOH (potassium hydroxide) and incubated at 80°C in a water bath for 60 min with
occasional mixing of the cell suspension. The KOH-treated material was washed three times with PBS, pH
7.4, and adjusted to 10 mg (dry weight)/ml PBS. For cells grown in RPMI medium, the KOH-treated
material was sonicated into suspension using a probe sonicator (Fisher sonic dismembrator model 300
attached to GraLab model 451 high-accuracy digital electronic timer): 5 cycles of 60 s. A 0.1-ml aliquot
of the alkali-treated material was used for the chitosan measurement as described next.
The 0.1-ml sample was mixed with 0.1 ml of 1 M HCl, followed by the addition of 400 l of freshly
prepared 2.5% (wt/vol) sodium nitrite (catalog no. 237213; Sigma-Aldrich) with vortexing to mix. The
deamination and depolymerization reactions were continued for 15 min at 25°C. Next, 200 l of 12.5%
(wt/vol) ammonium sulfamate (catalog no. 228745; Sigma-Aldrich) was added slowly to neutralize
unreacted sodium nitrite. After 5 min of incubation at 25°C, 200 l of 0.25% (wt/vol) MBTH prepared in
water was added, and the reaction mixture was incubated at 37°C for 30 min. After the incubation, 200
l of 0.5% ferric chloride (catalog no. 44944; Sigma-Aldrich) in water (wt/vol) was added, and the
contents were mixed and then incubated at 37°C for 5 min. Finally, the reaction mixture was centrifuged
at 12,000  g for 5 min, and the absorbance of the supernatant was measured at 650 nm. Standard
curves were prepared from stocks of D-glucosamine hydrochloride (catalog no. G4875; Sigma-Aldrich) in
the concentration range of 10 to 100 nmol. The amount of cellular chitosan was expressed as nanomoles
of glucosamine monomer per milligram (dry weight) of the sample.
Isolation of C. neoformans cells from infected murine lungs for chitosan measurements.
Animals were infected intranasally with 107 colony-forming units (CFU) of desired strains after growing
them in YPD (50 ml) for 2 days at 300 rpm and 30°C. On day 7 postinfection (PI), the lungs of the infected
animals were excised and homogenized (PRO 200 homogenizer; Midsci, USA) in 2 ml of PBS. Homoge-
nized lung tissue was extracted by the addition of 8 ml of 6% (wt/vol) KOH and incubation at 80°C for
60 min. After the incubation, tissue homogenate was centrifuged at 3,750  g for 10 min at 25°C. The
pellet was suspended in 2 ml of PBS and passed sequentially through 100-m and then 40-m nylon
ﬁlters to remove insoluble tissue materials. After two rounds of washing with PBS (pH 7.4), pellets were
suspended in 400 l of PBS. The suspension was disrupted further by probe sonication as described
above, and the number of Cryptococcus cells was counted using a hemocytometer and an Olympus
CKX41 inverted microscope. Samples were subjected to chitosan measurement by the MBTH assay as
described above. The amount of chitosan was expressed as nanomoles of glucosamine per 107 yeast
cells.
Virulence and fungal burden assays. C. neoformans strains were grown at 30°C and 300 rpm for 2
days in 50 ml YPD. The cells were centrifuged, washed in endotoxin-free 1 PBS, and suspended in 5 ml
of the same. The cells were counted with a hemocytometer and diluted to 2 106 cells ml1. CBA/J
female mice (Jackson Laboratories) were anesthetized with an intraperitoneal injection (200 l) of
ketamine (8 mg/ml)/dexdomitor (0.05 mg/ml) mixture which was reversed by an intraperitoneal injection
of antisedan (200 l) (0.25 mg/ml). Mice were allowed to inhale 1 105 cells in 50 l, which were dripped
into the nares (59). For virulence assays, the mice were weighed before and during the course of
infection. Mice were sacriﬁced by CO2 asphyxiation if they reached 80% of their original body weight. At
this point, the mice appeared morbidly ill, displaying a rufﬂed coat, lethargy, a hunched posture, unstable
gait, and loss of appetite. For the determination of CFU, lung or brain from each mouse was placed in
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2.0 ml of 1 PBS (pH 7), homogenized, serially diluted, plated onto YPD agar supplemented with
100 mg/ml streptomycin and 100 mg/ml ampicillin, and incubated for 2 days at 30°C. The total number
of CFU per organ was calculated.
Generation of C. neoformans Cda1-speciﬁc antibody and immunoblot analysis. A recombinant
protein of C. neoformans Cda1 (amino acids 20 to 374) was expressed in E. coli and puriﬁed as described
previously (34). This protein was used as an antigen to generate afﬁnity-puriﬁed polyclonal antibody
through Thermo Fisher Scientiﬁc, IL, USA. The speciﬁcity of the antibody to Cda1 protein was conﬁrmed
by hybridization to cell lysates of various single Cda gene deletion strains (cda1, cda2, and cda3
strains). For the Western blot analysis, yeast cells were grown in 20 ml of YPD for 48 h. Cells were
collected by centrifugation and washed two times with PBS at 4°C, and cell pellets were ﬂash frozen and
stored at 80°C. For the preparation of whole-cell lysate, each frozen cell pellet was suspended in 1.5ml of
lysis buffer (100mM Tris-HCl [pH 8] containing 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 1mM
phenylmethylsulfonyl ﬂuoride [PMSF], and cOmplete ULTRA tablet Mini EDTA-free [Roche Diagnostics,
Germany]) in a 2-ml tube. Then, 0.5ml of 0.5-mm zirconia beads (BioSpec Products, USA) was added, and the
cells were broken using a minibead beater (Biospec Products, Bartlesville, OK) for eight cycles of 30 s with
2min cooling on ice. Broken cells were centrifuged at 10,000  g at 4°C, and the supernatant was collected
and used as whole-cell lysate after mixing with sterile glycerol to a ﬁnal concentration of 5% (vol/vol). Protein
concentration was determined using a BCA protein assay kit (Thermo-Fisher, USA). Samples of 50g of
protein were separated on a 12% Stain-Free SDS-polyacrylamide gel (Bio-Rad). Protein was transferred to a
nitrocellulose membrane using a Bio-Rad protein transfer system. Blots were blocked in 5% milk containing
0.2% BSA in Tris-buffered saline (pH 7.4) with 0.1% Tween 20. Cda1-speciﬁc antibody was used at a 1:4,000
dilution, and the blot was incubated overnight at 4°C. HRP-conjugated anti-rabbit IgG secondary antibody
(catalog no. A6154; Sigma-Aldrich, USA) was used at a 1:5,000 dilution, and the blot was incubated for 1 h at
25°C. Finally, the blot was incubated with Clarity Western ECL substrate (catalog no. 170-5060; Bio-Rad,
Hercules, CA), and the image was acquired through a ChemiDoc Touch Imaging system (Bio-Rad, Hercules,
CA). Subcellular fractionation to determine the localization of Cda1 was carried out essentially as described by
Gilbert et al. (36).
Isolation of fungal cells from infected lung for RNA extraction. CBA/J mice were infected
intranasally as described above with 107 CFU of strain KN99. At day 7 PI, lungs were excised and
homogenized with 2 ml of water in the presence of 100 U of RNase inhibitor (catalog no. N8080119;
ThermoFisher Scientiﬁc, USA) at 4°C. The lung homogenate was centrifuged, the pellet was washed two
times with cold water with vortexing before being ﬁnally ﬁltered through 100-m and 40-m nylon
ﬁlters. As a control sample, KN99 cells from the culture used for infection was subjected to wash and
ﬁltration procedures used for lung homogenates. Isolated fungal cells were subjected to RNA puriﬁcation
as described previously using RNeasy plant minikit (Qiagen, GmbH, Germany) (57). Total RNA (0.5 g) was
used for ﬁrst-strand cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) per the
manufacturer’s instructions. The resulting cDNA was used as a template in quantitative PCR using SsoFast
EvaGreen Supermix (Bio-Rad, Hercules, CA) according to the manufacturer’s recommendations. The
CFX96 real-time system (Bio-Rad, Hercules, CA) was used as the ﬂuorescence detector with the following
protocol for the PCR. The initial denaturation step was 30 s at 95°C, followed by 40 cycles, with 1 cycle
consisting of 95°C for 5 s and 20 s at 60°C. A melting curve was measured at the end of each reaction to
conﬁrm that a single product was ampliﬁed.
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